Drug
PF 08052667
PF 08052667: highest development phase Phase 1, developed by Pfizer. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Pfizer
Trials
| Drug | Phase | Indication |
|---|---|---|
| PF-08052667 NCT07206225 | Phase 1 | Non-muscle Invasive Bladder Cancer |
Latest
No recent events.
Follow PF 08052667 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.